A perspective on the changing landscape of HTS
A Lanne, LEJ Usselmann, P Llowarch… - Drug Discovery …, 2023 - Elsevier
Highlights•Drug discovery target portfolios are changing, with an increasing focus on
previously intractable targets.•In response to this, a range of new small-molecule modalities …
previously intractable targets.•In response to this, a range of new small-molecule modalities …
The Discovery of New Inhibitors of Insulin-Regulated Aminopeptidase by a High-Throughput Screening of 400,000 Drug-like Compounds
J Gising, S Honarnejad, M Bras, GL Baillie… - International Journal of …, 2024 - mdpi.com
With the ambition to identify novel chemical starting points that can be further optimized into
small drug-like inhibitors of insulin-regulated aminopeptidase (IRAP) and serve as potential …
small drug-like inhibitors of insulin-regulated aminopeptidase (IRAP) and serve as potential …
[HTML][HTML] High-throughput differential scanning fluorimetry (DSF) and cellular thermal shift assays (CETSA): Shifting from manual to automated screening
CS Hansel, A Lanne, H Rowlands, J Shaw, MJ Collier… - SLAS technology, 2023 - Elsevier
Biophysical affinity screening is increasingly being adopted as a high-throughput hit finding
technique in drug discovery. Automation is highly beneficial to high-throughput screening …
technique in drug discovery. Automation is highly beneficial to high-throughput screening …
Screening, synthesis and biochemical characterization of SARS-CoV-2 protease inhibitors
M Bagdonas, K Čerepenkaitė, A Mickevičiūtė… - International journal of …, 2023 - mdpi.com
The severe acute respiratory syndrome-causing coronavirus 2 (SARS-CoV-2) papain-like
protease (PLpro) and main protease (Mpro) play an important role in viral replication events …
protease (PLpro) and main protease (Mpro) play an important role in viral replication events …
Advancing KRAS drug discovery: A deep dive into biochemical, biophysical, and cellular assays for the identification and optimization of KRAS inhibitors
AN Milin, JP Giddens, A Marquez - RAS Drug Discovery, 2025 - Elsevier
KRAS has been implicated in various cancers and has long been considered an
undruggable target. Recent advances in drug discovery have enabled new avenues for …
undruggable target. Recent advances in drug discovery have enabled new avenues for …